
Robert S. Cabral
Examiner (ID: 7026)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618, 1614 |
| Total Applications | 971 |
| Issued Applications | 558 |
| Pending Applications | 83 |
| Abandoned Applications | 345 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20599072
[patent_doc_number] => 20260077075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
[patent_app_type] => utility
[patent_app_number] => 19/395958
[patent_app_country] => US
[patent_app_date] => 2025-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19395958
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/395958 | RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | Nov 19, 2025 | Pending |
Array
(
[id] => 20599071
[patent_doc_number] => 20260077074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
[patent_app_type] => utility
[patent_app_number] => 19/395907
[patent_app_country] => US
[patent_app_date] => 2025-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19395907
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/395907 | RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | Nov 19, 2025 | Pending |
Array
(
[id] => 20349707
[patent_doc_number] => 20250346559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION, KIT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/274714
[patent_app_country] => US
[patent_app_date] => 2025-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19274714
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/274714 | COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION, KIT AND USE THEREOF | Jul 20, 2025 | Pending |
Array
(
[id] => 20517682
[patent_doc_number] => 20260041785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => POLYGLYCEROL-CONJUGATED LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 19/238030
[patent_app_country] => US
[patent_app_date] => 2025-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19238030
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/238030 | POLYGLYCEROL-CONJUGATED LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME | Jun 12, 2025 | Pending |
Array
(
[id] => 20533849
[patent_doc_number] => 12550895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Dispenser and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 19/220988
[patent_app_country] => US
[patent_app_date] => 2025-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 10438
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19220988
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/220988 | Dispenser and method of use thereof | May 27, 2025 | Issued |
Array
(
[id] => 20348467
[patent_doc_number] => 20250345319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => Anticancer Compositions
[patent_app_type] => utility
[patent_app_number] => 19/217221
[patent_app_country] => US
[patent_app_date] => 2025-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19217221
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/217221 | Anticancer Compositions | May 22, 2025 | Pending |
Array
(
[id] => 20348618
[patent_doc_number] => 20250345470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
[patent_app_type] => utility
[patent_app_number] => 19/204235
[patent_app_country] => US
[patent_app_date] => 2025-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19204235
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/204235 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | May 8, 2025 | Issued |
Array
(
[id] => 19982715
[patent_doc_number] => 20250120937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 19/002866
[patent_app_country] => US
[patent_app_date] => 2024-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002866
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002866 | Therapeutics and method for treating osteoarthritis | Dec 26, 2024 | Issued |
Array
(
[id] => 19700006
[patent_doc_number] => 12194004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Nano-delivery carrier for targeted tumor administration and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/788060
[patent_app_country] => US
[patent_app_date] => 2024-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 3486
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18788060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/788060 | Nano-delivery carrier for targeted tumor administration and application thereof | Jul 28, 2024 | Issued |
Array
(
[id] => 19947170
[patent_doc_number] => 12318508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Compositions for treatment of discogenic pain, and processes for making and using the same
[patent_app_type] => utility
[patent_app_number] => 18/732203
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 7147
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732203
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/732203 | Compositions for treatment of discogenic pain, and processes for making and using the same | Jun 2, 2024 | Issued |
Array
(
[id] => 20391634
[patent_doc_number] => 20250367109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => DEVICES, SYSTEMS, AND METHODS FOR IMPROVED BONE REMODELING
[patent_app_type] => utility
[patent_app_number] => 18/732532
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/732532 | DEVICES, SYSTEMS, AND METHODS FOR IMPROVED BONE REMODELING | Jun 2, 2024 | Pending |
Array
(
[id] => 19584863
[patent_doc_number] => 20240382420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
[patent_app_type] => utility
[patent_app_number] => 18/665612
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/665612 | Immunomodulating treatments of body cavities | May 15, 2024 | Issued |
Array
(
[id] => 19543382
[patent_doc_number] => 20240360418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => METHODS FOR REDUCING ELEVATED GLUCOSE LEVELS
[patent_app_type] => utility
[patent_app_number] => 18/630991
[patent_app_country] => US
[patent_app_date] => 2024-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/630991 | METHODS FOR REDUCING ELEVATED GLUCOSE LEVELS | Apr 8, 2024 | Pending |
Array
(
[id] => 19709107
[patent_doc_number] => 20250019249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/616147
[patent_app_country] => US
[patent_app_date] => 2024-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18616147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/616147 | FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF | Mar 24, 2024 | Pending |
Array
(
[id] => 19792237
[patent_doc_number] => 12233160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Dried nanoparticle compositions
[patent_app_type] => utility
[patent_app_number] => 18/609128
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 39
[patent_no_of_words] => 26560
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609128
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609128 | Dried nanoparticle compositions | Mar 18, 2024 | Issued |
Array
(
[id] => 19447242
[patent_doc_number] => 20240307372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITIONS AND METHODS TO IMPROVE BENEFIT OF SUBOPTIMALLY ADMINISTERED THERAPEUCTICS FOR THE TREATMENT OF BENIGN AND NEOPLASTIC DISEASES, INFECTIONS, INFLAMMATORY, METABOLIC AND IMMUNOLOGIAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/605757
[patent_app_country] => US
[patent_app_date] => 2024-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18605757
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/605757 | COMPOSITIONS AND METHODS TO IMPROVE BENEFIT OF SUBOPTIMALLY ADMINISTERED THERAPEUCTICS FOR THE TREATMENT OF BENIGN AND NEOPLASTIC DISEASES, INFECTIONS, INFLAMMATORY, METABOLIC AND IMMUNOLOGIAL DISEASES | Mar 13, 2024 | Pending |
Array
(
[id] => 19233815
[patent_doc_number] => 20240191007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/587211
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587211
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587211 | SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF | Feb 25, 2024 | Pending |
Array
(
[id] => 19156202
[patent_doc_number] => 20240148909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => EYE DROP COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/405670
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405670
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/405670 | Eye drop composition | Jan 4, 2024 | Issued |
Array
(
[id] => 19496626
[patent_doc_number] => 20240335644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/403636
[patent_app_country] => US
[patent_app_date] => 2024-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 173473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18403636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/403636 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE | Jan 2, 2024 | Abandoned |
Array
(
[id] => 19297812
[patent_doc_number] => 20240226378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => SOLID SUBSTRATES FOR PROMOTING CELL AND TISSUE GROWTH
[patent_app_type] => utility
[patent_app_number] => 18/543199
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543199
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543199 | Solid substrates for promoting cell and tissue growth | Dec 17, 2023 | Issued |